We are advised by Bridge to Life, Ltd. that journalists and other readers should disregard the news release, Bridge to Life™ Secures FDA De Novo Clearance for VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System, the First Device Cleared in the U.S. for Hypothermic Oxygenated Perfusion of Donor Livers, issued 20-Jan-2026 over PR Newswire.

SOURCE Bridge to Life, Ltd.